We found that lncRNA‐HIT could evaluate the stability of ZEB1 and then increase the ZEB1 occupancy of the promoter region in CDH1. The interaction of lncRNA‐HIT and ZEB1 may be a potential target for NSCLC therapy. Here, CDH1 is linked to non-small cell lung carcinoma.